Oxoid, a world leading microbiology brand, offers a convenient enzyme immunoassay for the rapid and reliable detection of norovirus, the virus responsible for ‘winter vomiting disease’. IDEIA™ Norovirus provides sensitive and specific results in less than 2 hours, allowing outbreaks to be identified quickly and enabling appropriate measures to contain the outbreak to be initiated at the earliest opportunity.
A novel, patented mosquito-killing technology developed by U.S. Army researchers under a long-term, joint-development agreement between the Walter Reed Army Institute of Research , the United States Army Medical Research and Materiel Command, and the U.S.
Using the Genome Sequencer System from 454 Life Sciences, a Roche company, French scientists have identified a small virus that can actually be parasitic to a larger one. The 50 nm virus, named Sputnik, is associated with a new strain of the giant Acanthamoeba polyphaga mimivirus (APMV) and is believed to represent a currently unknown family of viruses. The study, entitled “The virophage as a unique parasite of the giant mimivirus,” appeared in the September 4th issue of Nature (1).
Accelr8 Technology Corporation (Amex: AXK) announced study results today that were presented at the joint sessions of the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the Infectious Diseases Society of America (IDSA), October 25-29 in Washington, DC.
A probiotic bacterium, Lactobacillus plantarum 299, has been used to out-compete the dangerous bacteria that cause respiratory illness in ventilated patients. Research published in BioMed Central’s open access journal Critical Care describes how applying a bacterial solution in place of normal antiseptics is effective in preventing the most common cause of ventilator-associated pneumonia (VAP).
A new University of Colorado at Boulder study indicates that not only do human hands harbor far higher numbers of bacteria species than previously believed, women have a significantly greater diversity of microbes on their palms than men.
The American Society for Microbiology (ASM) and the Foundation for Innovative New Diagnostics (FIND) have signed a Memorandum of Understanding confirming their agreement to work in partnership for projects aimed at strengthening infectious disease diagnosis and service integration in resource-poor and transitional countries.